Abstract-We determined whether genetic deficiency of angiotensin II Type 1A (AT 1A ) receptors in mice results in altered neuronal responsiveness and reduced cardiovascular reactivity to stress. Telemetry devices were used to measure mean arterial pressure, heart rate, and activity. Before stress, lower resting mean arterial pressure was recorded in AT 1AϪ/Ϫ (85Ϯ2 mm Hg) than in AT 1A ϩ/ϩ (112Ϯ2 mm Hg) mice; heart rate was not different between groups. Cage-switch stress for 90 minutes elevated blood pressure by ϩ24Ϯ2 mm Hg in AT 1A ϩ/ϩ and ϩ17Ϯ2 mm Hg in AT 1A Ϫ/Ϫ mice (PϽ0.01), and heart rate increased by ϩ203Ϯ9 bpm in AT 1A ϩ/ϩ and ϩ121Ϯ9 bpm in AT 1A Ϫ/Ϫ mice (PϽ0.001). Locomotor activation was less in AT 1A Ϫ/Ϫ (3.0Ϯ0.4 U) than in AT 1A ϩ/ϩ animals (6.0Ϯ0.4 U), but differences in blood pressure and heart rate persisted during nonactive periods. In contrast to wild-type mice, spontaneous baroreflex sensitivity was not inhibited by stress in AT 1A Ϫ/Ϫ mice. After cage-switch stress, c-Fos immunoreactivity was less in the paraventricular (PϽ0.001) and dorsomedial (Pϭ0.001) nuclei of the hypothalamus and rostral ventrolateral medulla (PϽ0.001) in AT 1AϪ/Ϫ compared with AT 1A ϩ/ϩ mice. Conversely, greater c-Fos immunoreactivity was observed in the medial nucleus of the amygdala, caudal ventrolateral medulla, and nucleus of the solitary tract (PϽ0.001) of AT 1A Ϫ/Ϫ compared with AT 1A ϩ/ϩ mice. Greater activation of the amygdala suggests that AT 1A receptors normally inhibit the degree of stress-induced anxiety, whereas the lesser activation of the hypothalamus and rostral ventrolateral medulla suggests that AT 1A receptors play a key role in autonomic cardiovascular reactions to acute aversive stress, as well as for stress-induced inhibition of the baroreflex. Key Words: receptors Ⅲ angiotensin II Ⅲ stress Ⅲ blood pressure Ⅲ heart rate Ⅲ immunohistochemistry Ⅲ mice C ardiovascular reactivity, a rapid sympathetically mediated increase in blood pressure in response to aversive stress, is considered a risk factor for both hypertension and heart disease. 1,2 To date, the central mechanisms that control cardiovascular reactivity are not fully elucidated. However, it is plausible that the regulation of stress reactivity occurs at least at 3 major central nervous system levels. The first level includes the formation of an emotional reaction to a stimulus by cortico-limbic structures. The second consists of the activation of autonomic and endocrine outputs to the periphery by hypothalamic-brain stem circuits. The third involves suppression of negative feedback signals from baroreceptors, which would otherwise effectively counteract cardiovascular activation.Angiotensin II (Ang II) is increasingly recognized as an important modulator of cardiovascular reactivity to stress at several central nervous system levels. First, Ang II is implicated in modulating anxiety 3 and may thereby influence the integration of emotional and behavioral reactions to aversive stimuli at the limbic level. Second, Ang II is critically involved,...